A Drug-Drug Interaction Study Between ATI-2173 and Tenofovir Disoproxil Fumarate in Healthy Subjects

NCT05137548 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interaction

Interventions

DRUG: ATI-2173 50 mg
DRUG: Tenofovir 300Mg Oral Tablet

Sponsor

Antios Therapeutics, Inc